Literature DB >> 25676312

Synonymous codon usage affects the expression of wild type and F508del CFTR.

Kalpit Shah1, Yi Cheng2, Brian Hahn3, Robert Bridges2, Neil A Bradbury2, David M Mueller4.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel composed of 1480 amino acids. The major mutation responsible for cystic fibrosis results in loss of amino acid residue, F508 (F508del). Loss of F508 in CFTR alters the folding pathway resulting in endoplasmic-reticulum-associated degradation. This study investigates the role of synonymous codon in the expression of CFTR and CFTR F508del in human HEK293 cells. DNA encoding the open reading frame (ORF) for CFTR containing synonymous codon replacements was expressed using a heterologous vector integrated into the genome. The results indicate that the codon usage greatly affects the expression of CFTR. While the promoter strength driving expression of the ORFs was largely unchanged and the mRNA half-lives were unchanged, the steady-state levels of the mRNA varied by as much as 30-fold. Experiments support that this apparent inconsistency is attributed to nonsense mediated decay independent of exon junction complex. The ratio of CFTR/mRNA indicates that mRNA containing native codons was more efficient in expressing mature CFTR as compared to mRNA containing synonymous high-expression codons. However, when F508del CFTR was expressed after codon optimization, a greater percentage of the protein escaped endoplasmic-reticulum-associated degradation resulting in considerable levels of mature F508del CFTR on the plasma membrane, which showed channel activity. These results indicate that codon usage has an effect on mRNA levels and protein expression, for CFTR, and likely on chaperone-assisted folding pathway, for F508del CFTR.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CFTR; CFTR F508del; nonsense mediated decay; protein folding; synonymous codon usage

Mesh:

Substances:

Year:  2015        PMID: 25676312      PMCID: PMC4355305          DOI: 10.1016/j.jmb.2015.02.003

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  107 in total

1.  EJC-independent degradation of nonsense immunoglobulin-mu mRNA depends on 3' UTR length.

Authors:  Marc Bühler; Silvia Steiner; Fabio Mohn; Alexandra Paillusson; Oliver Mühlemann
Journal:  Nat Struct Mol Biol       Date:  2006-04-23       Impact factor: 15.369

2.  Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.

Authors:  Ying Wang; M Claire Bartlett; Tip W Loo; David M Clarke
Journal:  Mol Pharmacol       Date:  2006-04-19       Impact factor: 4.436

3.  Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response.

Authors:  Lawrence B Gardner
Journal:  Mol Cell Biol       Date:  2008-03-24       Impact factor: 4.272

4.  Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

Authors:  W Dalemans; P Barbry; G Champigny; S Jallat; K Dott; D Dreyer; R G Crystal; A Pavirani; J P Lecocq; M Lazdunski
Journal:  Nature       Date:  1991 Dec 19-26       Impact factor: 49.962

5.  Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.

Authors:  Wilson Yu; Patrick Kim Chiaw; Christine E Bear
Journal:  J Biol Chem       Date:  2011-05-21       Impact factor: 5.157

6.  The silent codon change I507-ATC->ATT contributes to the severity of the ΔF508 CFTR channel dysfunction.

Authors:  Ahmed Lazrak; Lianwu Fu; Vedrana Bali; Rafal Bartoszewski; Andras Rab; Viktoria Havasi; Steve Keiles; John Kappes; Ranjit Kumar; Elliot Lefkowitz; Eric J Sorscher; Sadis Matalon; James F Collawn; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2013-08-01       Impact factor: 5.191

7.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

Review 8.  Codon usage: nature's roadmap to expression and folding of proteins.

Authors:  Evelina Angov
Journal:  Biotechnol J       Date:  2011-05-12       Impact factor: 4.677

9.  Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis.

Authors:  Rebecca A Chanoux; Ronald C Rubenstein
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

10.  Diminished self-chaperoning activity of the DeltaF508 mutant of CFTR results in protein misfolding.

Authors:  Adrian W R Serohijos; Tamás Hegedus; John R Riordan; Nikolay V Dokholyan
Journal:  PLoS Comput Biol       Date:  2008-02-29       Impact factor: 4.475

View more
  13 in total

1.  Synonymous variants that disrupt messenger RNA structure are significantly constrained in the human population.

Authors:  Jeffrey B S Gaither; Grant E Lammi; James L Li; David M Gordon; Harkness C Kuck; Benjamin J Kelly; James R Fitch; Peter White
Journal:  Gigascience       Date:  2021-04-05       Impact factor: 6.524

2.  Role for ribosome-associated complex and stress-seventy subfamily B (RAC-Ssb) in integral membrane protein translation.

Authors:  Ligia Acosta-Sampson; Kristina Döring; Yuping Lin; Vivian Y Yu; Bernd Bukau; Günter Kramer; Jamie H D Cate
Journal:  J Biol Chem       Date:  2017-10-02       Impact factor: 5.157

3.  Rare-variant pathogenicity triage and inclusion of synonymous variants improves analysis of disease associations of orphan G protein-coupled receptors.

Authors:  Ridge Dershem; Raghu P R Metpally; Kirk Jeffreys; Sarathbabu Krishnamurthy; Diane T Smelser; Michal Hershfinkel; David J Carey; Janet D Robishaw; Gerda E Breitwieser
Journal:  J Biol Chem       Date:  2019-10-18       Impact factor: 5.157

4.  A synonymous codon change alters the drug sensitivity of ΔF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Vedrana Bali; Ahmed Lazrak; Purushotham Guroji; Lianwu Fu; Sadis Matalon; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2015-09-03       Impact factor: 5.191

5.  Evidence against resveratrol as a viable therapy for the rescue of defective ΔF508 CFTR.

Authors:  Ying Jai; Kalpit Shah; Robert J Bridges; Neil A Bradbury
Journal:  Biochim Biophys Acta       Date:  2015-09-02

6.  Lemur Tyrosine Kinase 2, a novel target in prostate cancer therapy.

Authors:  Kalpit Shah; Neil A Bradbury
Journal:  Oncotarget       Date:  2015-06-10

Review 7.  Codon bias and the folding dynamics of the cystic fibrosis transmembrane conductance regulator.

Authors:  Rafal Bartoszewski; Jaroslaw Króliczewski; James F Collawn; Arkadiusz Piotrowski; Anna Janaszak Jasiecka; Sylwia Bartoszewska; Briana Vecchio-Pagan; Lianwu Fu; Aleksandra Sobolewska; Sadis Matalon; Garry R Cutting; Steven M Rowe
Journal:  Cell Mol Biol Lett       Date:  2016-10-19       Impact factor: 5.787

8.  Rescue of mutant rhodopsin traffic by metformin-induced AMPK activation accelerates photoreceptor degeneration.

Authors:  Dimitra Athanasiou; Monica Aguila; Chikwado A Opefi; Kieron South; James Bellingham; Dalila Bevilacqua; Peter M Munro; Naheed Kanuga; Francesca E Mackenzie; Adam M Dubis; Anastasios Georgiadis; Anna B Graca; Rachael A Pearson; Robin R Ali; Sanae Sakami; Krzysztof Palczewski; Michael Y Sherman; Philip J Reeves; Michael E Cheetham
Journal:  Hum Mol Genet       Date:  2017-01-15       Impact factor: 6.150

9.  Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis.

Authors:  Vedrana Bali; Ahmed Lazrak; Purushotham Guroji; Sadis Matalon; Zsuzsanna Bebok
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

10.  Alteration of protein function by a silent polymorphism linked to tRNA abundance.

Authors:  Sebastian Kirchner; Zhiwei Cai; Robert Rauscher; Nicolai Kastelic; Melanie Anding; Andreas Czech; Bertrand Kleizen; Lynda S Ostedgaard; Ineke Braakman; David N Sheppard; Zoya Ignatova
Journal:  PLoS Biol       Date:  2017-05-16       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.